Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

Both proprietary and nonproprietary medicines are expected to undergo rigorous preapproval testing and both should meet stringent health authority regulatory requirements related to quality to obtain approval. Nonproprietary (also known as copy, or generic) medicines, which base their authorization...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Jorge, Chiquete, Erwin, Boyko, Alexey, Beran, Roy G, Strauch, Jorge Barahona, Milojevic, Snezana, Frider, Nadina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933568/
https://www.ncbi.nlm.nih.gov/pubmed/27418809
http://dx.doi.org/10.2147/DDDT.S106802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933568/
https://www.ncbi.nlm.nih.gov/pubmed/27418809
http://dx.doi.org/10.2147/DDDT.S106802

Ejemplares similares